Induction of Anchorage-Independent Growth by Amphiregulin

References

• Adam R. M., Davies D. E. The heparin binding domain of amphiregulin and heparin-binding epidermal growth factor does not account for all of the differential effects of these growth factors. Eur. J. Clin. Invest 1995; 25(Suppl. 2)pA51
   Google Scholar
• Adam R. M., Drummond D. R., Solic N., Holt S. J., Sharma R. P., Chamberlin S. G., Davies D. E. Modulation of the receptor binding affinity of amphiregulin by modification of its carboxyl terminal tail. Biochim. Biophys. Acta 1995; 1266: 83–90
   Google Scholar
• Beerli R. R., Hynes N. E. Epidermal growth factor-related peptides activate distinct subsets of erbB receptros and differ in their biological activities. J. Biol. Chern 1996; 271: 6071–6076
   PubMed Web of Science ®Google Scholar
• Carpenter G., Cohen S. Epidermal growth factor. J. Biol. Chern 1990; 265: 7709–7712
   PubMed Web of Science ®Google Scholar
• Carpenter G., Wahl M. I. The Epidermal Growth Factor Family. Peptide Growth Factors and their Receptors, M. B. Sporn, A. B. Roberts. Springer-Verlag, New York Inc. 1991; 69–171
   Google Scholar
• Cook P. W., Mattox P. A., Keeble W. W., Pittelkow M. R., Plowman G. D., Shoyab M., Adelman J. P., Shipley G. D. A heparin sulphate-regulated human keratinocyte autocrine factor is similar or identical to amphiregulin. Mol. Cell. Biol 1991; 11: 2547–2557
   PubMed Web of Science ®Google Scholar
• Davies D. E., Farmer S., White J., Senior P. V., Warnes S. L., Alexander P. Contribution of host-derived growth factors to in vivo growth of a transplantable murine mammary carcinoma. Br. J. Cancer 1994; 70: 263–269
   Google Scholar
• De Larco J. E., Todaro G. J. Epithelial and fibroblastic rat kidney cell clones: Epidermal growth factor (EGF) receptors and the effect of murine sarcoma virus transformation. J. Cell Physiol 1978; 94: 335–342
   PubMed Web of Science ®Google Scholar
• Derynck R. Transforming growth factor-α. Cell 1988; 54: 593–595
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Abraham J. A., Miller J., Fiddes J. C., Klagsbrun M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991; 251: 936–939
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Lau K., Besner G. E., Klagsbrun M. Structure of heparin-binding EGF-like growth factor. J. Biol. Chem 1992; 267: 6205–6212
   PubMed Web of Science ®Google Scholar
• Higashiyama S., Abraham J. A., Klagsbrun M. Heparin-binding EGF-like growth factor stimulation of smooth muscle cell migration: dependence on interactions with cell surface heparan sulphate. J. Cell Biol 1993; 122: 933–940
   PubMed Web of Science ®Google Scholar
• Johnson G. R., Saeki T., Auersperg N., Gordon A. W., Shoyab M., Salomon D. S., Stromberg K. Response to and expression of amphiregulin by ovarian carcinoma and normal ovarian surface epithelial cells: nuclear localization of endogenous amphiregulin. Biochem. Biophys. Res. Commun 1991; 180: 481–488
   Google Scholar
• Johnson G. R., Saeki T., Gordon A. W., Shoyab M., Salomon D. S., Stromberg K. Autocrine action of amphiregulin in a colon carcinoma cell line and immuno-cytochemical localization of amphiregulin in human colon. J. Cell Biol 1992; 118: 741–751
   PubMedGoogle Scholar
• Johnson G. R., Wong L. Heparan sulphate is essential to amphiregulin-induced mitogenic signalling by the epidermal growth factor receptor. J. Biol. Chern 1994; 269: 27149–27154
   PubMed Web of Science ®Google Scholar
• Karunagaran D., Tzahar E., Liu N., Wen D., Yarden Y. Neu differentiation factor inhibits EGF binding. J. Biol. Chem 1995; 270: 9982–9990
   PubMedGoogle Scholar
• Klagsbrun M., Baird A. A dual receptor system is required for basic fibroblast growth factor activity. Cell 1991; 67: 229–231
   PubMed Web of Science ®Google Scholar
• Lazar E., Watanabe S., Dalton S., Sporn M. B. Transforming growth factor-a: mutation of aspartic acid 47 and leucine 48 results in different biological activities. Mol. Cell. Biol 1988; 8: 1247–1252
   PubMed Web of Science ®Google Scholar
• Li S., Plowman G. D., Buckley S. D., Shipley G. D. Heparin inhibition of autonomous growth implicates amphiregulin as an autocrine growth factor for normal human mammary epithelial cells. J. Cell. Physiol 1992; 153: 103–111
   PubMedGoogle Scholar
• Matsunami R. K., Yette M. L., Stevens A., Niyogi S. K. Mutational analysis of leucine 47 in human epidermal growth factor. J. Cell. Biochem 1991; 46: 242–249
   PubMed Web of Science ®Google Scholar
• Modrell B., McDonald V. L., Shoyab M. The interaction of AR with nuclei and putative nuclear localization sequence binding proteins. Growth Factors 1992; 7: 305–314
   PubMed Web of Science ®Google Scholar
• Normanno N., Selvam M. P., Qi C.-H., Saeki T., Johnson G., Kim N., Ciardiello F., Shoyab M., Plowman G., Brandt R., Todaro G., Salomon D. S. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB2-transformed human mammary epithelial cells. Proc. Natl Acad. Sci. USA 1994; 91: 2790–2794
   Google Scholar
• Piepkorn M., Lo C., Plowman G. D. Amphiregulin-dependent proliferation of cultured human keratinocytes: autocrine growth, the effects of exogenous recombinant cytokine, and apparent requirement for heparin-like glycosaminoglycans. J. Cell. Physiol 1994; 159: 114–120
   PubMed Web of Science ®Google Scholar
• Richter A. Studies on the interactions of the epidermal growth factor receptor with epidermal growth factor and transforming growth factor alpha to aid development of a growth factor antagonist. Ph.D. Thesis, University of Southampton, UK 1991
   Google Scholar
• Rizzino A. Soft agar growth assays for transforming growth factors and mitogenic peptides. Methods in Enzymology, D. Barnes, D. A. Sirbasku. Academic Press Inc. (London), Ltd. 1987; Vol. 146: 341–352
   Google Scholar
• Shing Y., Christofori G., Hanahan D., Ono Y., Sasada R., Igarashi K., Folkman J. Betacellulin: a mitogen from pancreatic β cell tumours. Science 1993; 259: 1604–1607
   PubMed Web of Science ®Google Scholar
• Shoyab M., McDonald V. L., Bradley J. G., Todaro G. J. Amphiregulin: a bifunctional growth-modulating glycoprotein produced by the phorbol 12-myristate 13-acetate treated human breast adenocarcinoma cell line MCF-7. Proc. Natl Acad. Sci. USA 1988; 85: 6528–6532
   PubMed Web of Science ®Google Scholar
• Shoyab M., Plowman G. D., McDonald V. L., Bradley J. G., Todaro G. J. Structure and function of human amphiregulin: a member of the epidermal growth factor family. Science 1989; 243: 1074–1076
   PubMed Web of Science ®Google Scholar
• Thompson S. A., Higashiyama S., Wood K., Pollitt N. S., Damm D., McEnroe G., Garrick B., Ashton N., Lau K., Hancock N., Klagsbrun M., Abraham J. A. Characterization of sequences within heparin-binding EGF-like growth factor that mediate interation with heparin. J. Biol. Chem 1994; 269: 2541–2549
   PubMed Web of Science ®Google Scholar
• Thorne B. A., Plowman G. D. The heparin-binding domain of amphiregulin necessitates the precursor pro-region for growth factor secretion. Mol. Cell Biol 1994; 14: 1635–1646
   PubMedGoogle Scholar